Kwong Y. Tsang

6.7k total citations
109 papers, 5.2k citations indexed

About

Kwong Y. Tsang is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Kwong Y. Tsang has authored 109 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Immunology, 54 papers in Oncology and 35 papers in Molecular Biology. Recurrent topics in Kwong Y. Tsang's work include Immunotherapy and Immune Responses (53 papers), Cancer Immunotherapy and Biomarkers (31 papers) and Monoclonal and Polyclonal Antibodies Research (24 papers). Kwong Y. Tsang is often cited by papers focused on Immunotherapy and Immune Responses (53 papers), Cancer Immunotherapy and Biomarkers (31 papers) and Monoclonal and Polyclonal Antibodies Research (24 papers). Kwong Y. Tsang collaborates with scholars based in United States, Italy and United Kingdom. Kwong Y. Tsang's co-authors include Jeffrey Schlom, James L. Gulley, Philip M. Arlen, James W. Hodge, Caroline Jochéms, Massimo Fantini, Christopher R. Heery, Sofia R. Gameiro, Seth M. Steinberg and Ravi A. Madan and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Kwong Y. Tsang

103 papers receiving 5.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kwong Y. Tsang United States	38	3.5k	3.1k	1.5k	818	577	109	5.2k
Emma Di Carlo Italy	45	4.0k 1.1×	2.9k 0.9×	1.8k 1.2×	401 0.5×	715 1.2×	125	6.1k
Douglas G. McNeel United States	44	3.2k 0.9×	2.8k 0.9×	1.5k 1.0×	1.3k 1.6×	695 1.2×	179	5.1k
Vincent Ling United States	28	4.9k 1.4×	3.6k 1.2×	1.4k 1.0×	558 0.7×	338 0.6×	49	7.6k
Danielle Líénard Switzerland	47	5.3k 1.5×	3.3k 1.0×	2.4k 1.6×	492 0.6×	394 0.7×	89	7.1k
Hideto Tamura Japan	25	5.0k 1.4×	5.4k 1.7×	1.2k 0.8×	824 1.0×	315 0.5×	88	8.0k
John R. Yannelli United States	34	5.5k 1.6×	3.6k 1.2×	2.2k 1.5×	308 0.4×	597 1.0×	74	7.3k
Yong F. Li United States	27	4.3k 1.2×	4.7k 1.5×	1.4k 1.0×	380 0.5×	419 0.7×	43	5.9k
Gunnar Kvalheim Norway	43	1.8k 0.5×	2.9k 0.9×	1.7k 1.1×	571 0.7×	294 0.5×	173	5.5k
Ainhoa Arina United States	28	2.7k 0.8×	2.3k 0.7×	1.1k 0.7×	486 0.6×	288 0.5×	50	4.2k
Frédéric Triebel France	54	7.0k 2.0×	5.2k 1.7×	1.1k 0.7×	715 0.9×	679 1.2×	167	9.2k

Countries citing papers authored by Kwong Y. Tsang

Since Specialization

Citations

This map shows the geographic impact of Kwong Y. Tsang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kwong Y. Tsang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kwong Y. Tsang more than expected).

Fields of papers citing papers by Kwong Y. Tsang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kwong Y. Tsang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kwong Y. Tsang. The network helps show where Kwong Y. Tsang may publish in the future.

Co-authorship network of co-authors of Kwong Y. Tsang

This figure shows the co-authorship network connecting the top 25 collaborators of Kwong Y. Tsang. A scholar is included among the top collaborators of Kwong Y. Tsang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kwong Y. Tsang. Kwong Y. Tsang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fantini, Massimo, Kwong Y. Tsang, Kevin C. Conlon, et al.. (2024). Tregs, gMDSCs, and levels of soluble MICA as prognostic biomarkers for combined NEO-201 and pembrolizumab.. Journal of Clinical Oncology. 42(16_suppl). 2530–2530. 1 indexed citations

Romano, Alessandra, Nunziatina Laura Parrinello, Enrico La Spina, et al.. (2021). 883 An anti-carcinoma monoclonal antibody (mAb) NEO-201 can also target human acute myeloid leukemia (AML) cell lines in vitro. SHILAP Revista de lepidopterología. A925–A925. 3 indexed citations

Fantini, Massimo, et al.. (2020). The Monoclonal Antibody NEO-201 Enhances Natural Killer Cell Cytotoxicity Against Tumor Cells Through Blockade of the Inhibitory CEACAM5/CEACAM1 Immune Checkpoint Pathway. Cancer Biotherapy and Radiopharmaceuticals. 35(3). 190–198. 13 indexed citations

Zeligs, Kristen, Maria Pia Morelli, Justin M. David, et al.. (2020). Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian Cancer. Frontiers in Oncology. 10. 805–805. 8 indexed citations

Fantini, Massimo, Justin M. David, Hing C. Wong, et al.. (2019). An IL-15 Superagonist, ALT-803, Enhances Antibody-Dependent Cell-Mediated Cytotoxicity Elicited by the Monoclonal Antibody NEO-201 Against Human Carcinoma Cells. Cancer Biotherapy and Radiopharmaceuticals. 34(3). 147–159. 20 indexed citations

Kim, Richard D., Philip M. Arlen, Kwong Y. Tsang, et al.. (2017). Ensituximab (E) in patients (pts) with refractory metastatic colorectal cancer (mCRC): Results of a phase I/II clinical trial.. Journal of Clinical Oncology. 35(15_suppl). 3081–3081. 2 indexed citations

Gameiro, Sofia R., Anthony S. Malamas, M. Bernstein, et al.. (2016). Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell–Mediated Killing. International Journal of Radiation Oncology*Biology*Physics. 95(1). 120–130. 117 indexed citations

Boyerinas, Benjamin, Caroline Jochéms, Massimo Fantini, et al.. (2015). Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti–PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells. Cancer Immunology Research. 3(10). 1148–1157. 360 indexed citations

Gulley, James L., Ravi A. Madan, Kwong Y. Tsang, et al.. (2013). Immune Impact Induced by PROSTVAC (PSA-TRICOM), a Therapeutic Vaccine for Prostate Cancer. Cancer Immunology Research. 2(2). 133–141. 101 indexed citations

10.

Huen, Ngar‐Yee, Alan Lap‐Yin Pang, Jo A. Tucker, et al.. (2013). Up‐regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration‐resistant prostate cancer. International Journal of Cancer. 133(2). 373–382. 34 indexed citations

11.

Madan, Ravi A., Caroline Jochéms, Christopher R. Heery, et al.. (2013). Impact of androgen deprivation therapy on the thymus and the production of naïve T-cells. Journal for ImmunoTherapy of Cancer. 1(S1). 2 indexed citations

12.

Kamrava, Mitchell, Aparna H. Kesarwala, Ravi A. Madan, et al.. (2012). Long-term follow-up of prostate cancer patients treated with vaccine and definitive radiation therapy. Prostate Cancer and Prostatic Diseases. 15(3). 289–295. 10 indexed citations

13.

Correale, Pierpaolo, Maria Rotundo, Maria Teresa Del Vecchio, et al.. (2010). Regulatory (FoxP3+) T-cell Tumor Infiltration Is a Favorable Prognostic Factor in Advanced Colon Cancer Patients Undergoing Chemo or Chemoimmunotherapy. Journal of Immunotherapy. 33(4). 435–441. 173 indexed citations

14.

Correale, Pierpaolo, Maria Grazia Cusi, Maria Teresa Del Vecchio, et al.. (2005). Dendritic Cell-Mediated Cross-Presentation of Antigens Derived from Colon Carcinoma Cells Exposed to a Highly Cytotoxic Multidrug Regimen with Gemcitabine, Oxaliplatin, 5-Fluorouracil, and Leucovorin, Elicits a Powerful Human Antigen-Specific CTL Response with Antitumor Activity in Vitro. The Journal of Immunology. 175(2). 820–828. 61 indexed citations

15.

Wallace, Paul K., Kwong Y. Tsang, J. Goldstein, et al.. (2001). Exogenous antigen targeted to FcγRI on myeloid cells is presented in association with MHC class I. Journal of Immunological Methods. 248(1-2). 183–194. 46 indexed citations

16.

Yamaue, Hiroki, S. V. S. Kashmiri, Rosaria De Filippi, et al.. (1994). Enhanced Interleukin-2 Production in Human Tumor-Infiltrating Lymphocytes Engineered by 3'-Truncated Interleukin-2 Gene. Journal of Immunotherapy. 16(4). 262–274. 8 indexed citations

17.

Tsang, Kwong Y., S. V. S. Kashmiri, Rosaria De Filippi, et al.. (1993). A Human T Cell Line Engineered to Secrete Chimeric Monoclonal Antibody. Journal of Immunotherapy. 13(3). 143–152. 5 indexed citations

18.

Tsang, Kwong Y., Raymond P. Donnelly, G.M.P. Galbraith, & H. Hugh Fudenberg. (1986). Isoprinosine effects on interleukin-1 production in acquired immune deficiency syndrome (AIDS). International Journal of Immunopharmacology. 8(4). 437–441. 6 indexed citations

19.

Singh, Iqbal, Kwong Y. Tsang, & William S. Blakemore. (1978). Placenta-like alkaline phosphatases from human osteosarcoma cells.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(1). 193–8. 27 indexed citations

20.

Singh, Iqbal, Kwong Y. Tsang, & George D. Ludwig. (1974). Alkaline Phosphatase and Ultrastructural Alterations in Human Osteosarcoma Cells in Tissue Culture. European Surgical Research. 6(4). 247–263. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact